Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insertional mutagenesis inducing hypomyelination in transgenic mice

J M Orian1, A W Mitchell, W E Marshman

  • 1Neuroscience Research Laboratories, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

Journal of Neuroscience Research
|December 1, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to 'Do different treatment strategies of galcanezumab have similar effect on migraine?'

European journal of neurology·2020
Same author

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials.

European journal of neurology·2019
Same author

The emergent role of exosomes in glioma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2016
Same author

Use of tissue plasminogen activator in the treatment of shunt blockage secondary to intraventricular haemorrhage.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2016
Same author

Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging.

NMR in biomedicine·2014
Same author

Penicillin O.

Antibiotics & chemotherapy (Northfield, Ill.)·2014

Researchers created a unique mouse model (2-50) with a genetic mutation affecting myelin formation. This model aids in understanding myelin assembly and developing therapies for myelin disorders like multiple sclerosis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Multiple sclerosis (MS) research primarily focuses on immune-mediated damage to myelin.
  • The molecular genetics of myelin formation remain less explored.
  • Understanding myelin development is crucial for treating demyelinating diseases.

Purpose of the Study:

  • To generate and characterize a novel transgenic mouse model for studying myelin formation.
  • To investigate the genetic basis of myelination defects.
  • To establish a model for developing gene therapies for myelin repair.

Main Methods:

  • Generation of a transgenic mouse mutant (2-50) with an insertional mutation.
  • The transgene contains the myelin basic protein (MBP) promoter linked to the human c-myc gene.

Related Experiment Videos

  • In situ hybridization was used to determine transgene insertion site.

    • Main Results:

    • The 2-50 mice exhibit reduced myelination and a transient shivering phenotype.
    • The phenotype is attributed to insertional inactivation of a critical myelination gene, not c-myc expression.
    • The transgene insertion site was mapped to chromosome 9.

    Conclusions:

    • The 2-50 mouse model provides a unique tool for studying the molecular basis of myelin assembly.
    • This model is valuable for research into gene therapy strategies for remyelination in conditions like MS.